by Medical Data International in Irvine, Calif. (2 Park Plaza, Suite 750, Irvine 92714) .
Written in English
|Other titles||United States market for drug and intravenous fluid delivery and supplies|
|Series||Critical insight for the medical industry executive|
|Contributions||Medical Data International, Inc.|
|LC Classifications||HD9995.I583 U6779 1995|
|The Physical Object|
|Pagination||1 v. (various paging) :|
|LC Control Number||96126742|
The injectable drug delivery devices market is expected to register a CAGR of nearly %, during the forecast period, The market is segmented by device . The global drug delivery devices market is segmented on the basis of type, application and geography. The worldwide market for Drug Delivery Devices Market is expected to grow at a CAGR of roughly % over the next ten years, and will reach US$ 16, Mn in , from US$ 10, Mn in , according to a new (Prudour Research. Based on geography, the advanced drug delivery devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the advanced drug delivery devices market, with the U.S. accounting for a major share. The Pharmaceutical Drug Delivery Market is expected to grow from USD 1, billion in to USD 2, billion by , at a CAGR of % during the forecast period. The global pharmaceutical drug delivery market is highly competitive owing to the presence of several large and small players.
The opportunities presented in the drug delivery device market will entice drug companies to invest in R&D and to partner with device manufacturing companies to develop patient-centric products. This Medtech Report provides comprehensive data and analysis on the current state of the market for drug delivery devices in the US across a The report "Pharmaceutical Drug Delivery Market by Route (Oral (Tablet), Pulmonary (Nebulizer), Injectable, Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal), Application (Cancer, Diabetes), Patient Care Setting (Hospital)- COVID-1 Impact - Forecast to " is projected to reach USD 2, billion by from USD 1, billion in , at a CAGR of % during the. Medical device industry suppliers and outsourcers are helping to enable the latest drug-delivery tech. Drug-eluting technologies are moving beyond stents, thanks in part to the development of polymeric hydrogels engineered to respond to a range of different physical and chemical stimuli. devices since bioresorbable surgical sutures entered the market. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release ; Drug delivery .
Drug delivery systems (DDS) are an important component of drug development and therapeutics. The field is quite extensive and requires an encyclopedia to describe all the technologies. The aim of this book is to put together descriptions of important selective technologies used in DDS. Important drugs, new technologies such as nanoparticles, as well as important therapeutic applications, are. Before a company develops and submits for approval a new drug-delivery device, it should review how competitors and similar products are performing on the market. If there are no competitors — as is the case with “revolutionary” first-gen products — consider any issues that plagued products with the same intended use, or products. Dockets Management Food and Drug Administration Fishers Lane, Rm Rockville, MD All written comments should be identified with this document's docket number: FDAD Microchip drug delivery devices are currently being studied in the treatment of serious diseases such as breast cancer, multiple sclerosis, osteoporosis, Alzheimer's and Parkinson's is also being investigated as a device for organ transplantation by utilizing a microchip containing stem the device has been implanted, the stem cells would grow and proliferate inside the.